trendingVideos2390590https://zeenews.india.com/video/india/biological-e-limiteds-covid-vaccine-approved-for-trial-trial-will-be-done-on-children-of-5-18-years-2390590.html)
Videos
Biological E. Limited's COVID vaccine approved for trial, trial will be done on children of 5-18 years
The Drugs Controller General of India (DGCI) on Wednesday authorized Hyderabad-based Biological E. Ltd to conduct Phase 2 and 3 clinical trials for its anti-COVID vaccine named Corbevax on children aged 5 to 18 years with certain conditions.
The Drugs Controller General of India (DGCI) on Wednesday authorized Hyderabad-based Biological E. Ltd to conduct Phase 2 and 3 clinical trials for its anti-COVID vaccine named Corbevax on children aged 5 to 18 years with certain conditions.
Advertisement
